You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Aromatase Inhibitors

Showing 26 - 50 of 4,600
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atrophic Vaginitis, Breast Cancer Trial in United States (Vagifem® (vaginal 17ß-estradiol) questionnaire & menopause symptom

Active, not recruiting
  • Atrophic Vaginitis
  • Breast Cancer
  • Vagifem® (vaginal 17β-estradiol) questionnaire & menopause symptom checklist
  • Basking Ridge, New Jersey
  • +4 more
Oct 18, 2022

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Hormone Receptor Positive Tumor Trial in Durham (Abemaciclib,

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Jun 7, 2022

Breast Cancer Trial in Shanghai (OFS + Anastrozole, OFS + Exemestane)

Completed
  • Breast Cancer
  • OFS + Anastrozole
  • OFS + Exemestane
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Mar 28, 2022

Adherence, Medication Trial in Madison (Vaginal Renewal Program)

Terminated
Has Results
  • Adherence, Medication
  • Vaginal Renewal Program
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Sep 27, 2021

Breast Cancer Trial in Los Angeles (Carbohydrate restricted dietary intervention, standard of care aromatase inhibitors)

Terminated
  • Breast Cancer
  • Carbohydrate restricted dietary intervention
  • standard of care aromatase inhibitors
  • Los Angeles, California
    Cedars-Sinai Medical Center
Aug 27, 2021

Hormone Receptor Positive Breast Carcinoma, Breast Tumors, Tumors, Breast Trial in Italy (Liquid biopsy and CT scan)

Recruiting
  • Hormone Receptor Positive Breast Carcinoma
  • +6 more
  • Liquid biopsy and CT scan
  • Bergame, Bergamo, Italy
  • +6 more
Apr 13, 2023

Advanced Breast Cancer Trial in Italy (Abemaciclib, Aromatase Inhibitors)

Recruiting
  • Advanced Breast Cancer
  • Ancona, Italy
  • +43 more
Jan 31, 2022

Breast Cancer Trial in New Haven (Everolimus)

Terminated
Has Results
  • Breast Cancer
  • New Haven, Connecticut
    Yale University
Jan 12, 2022

Breast Cancer, Advanced Breast Cancer Trial in Shanghai (Everolimus 10 mg, CDK4/6 Inhibitor SHR6390, Aromatase inhibitor and

Not yet recruiting
  • Breast Cancer
  • Advanced Breast Cancer
  • Everolimus 10 mg
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 14, 2023

Breast Tumors, Cancer Survivor Trial in Shenzhen (Ture self-acupressure, Sham self-acupressure, Usual care)

Recruiting
  • Breast Neoplasms
  • Cancer Survivor
  • Ture self-acupressure
  • +2 more
  • Shenzhen, Guangdong, China
    The Huazhong University of Science and Technology Union Shenzhen
Aug 30, 2021

Breast Cancer Trial in Besançon (Letrozole, Anastrozole, Vinorelbine)

Terminated
  • Breast Cancer
  • Besançon, France
    CHU Besançon
Jan 29, 2021

Breast Cancer, Pain Trial in United States (acupuncture therapy, sham acupuncture)

Completed
  • Breast Cancer
  • Pain
  • acupuncture therapy
  • sham acupuncture
  • Antioch, California
  • +46 more
Dec 5, 2022

Tamoxifen and Aromatase Inhibitors on Platelet Proteins

Completed
  • Breast Cancer
    • Burlington, Vermont
      University of Vermont
    Sep 15, 2020

    Breast Cancer Trial in France (next-generation sequencing (NGS))

    Active, not recruiting
    • Breast Cancer
    • next-generation sequencing (NGS)
    • Metz, France
    • +9 more
    Aug 25, 2021

    Breast Cancer Metastatic Trial in Italy (Everolimus, Aromatase Inhibitors)

    Completed
    • Breast Cancer Metastatic
    • Ancona, AN, Italy
    • +15 more
    Dec 2, 2020

    Metastatic Breast Cancer, ER Positive Breast Cancer, HER2-negative Breast Cancer Trial in Prato (Thymidine kinase activity)

    Recruiting
    • Metastatic Breast Cancer
    • +2 more
    • Thymidine kinase activity
    • Prato, Tuscany, Italy
      Hospital Santo Stefano
    Dec 10, 2020

    Breast Cancer Trial in Lund (Letrozole, Letrozole and atorvastatin, Fulvestrant)

    Recruiting
    • Breast Cancer
    • Lund, Sweden
      Lund University Hospital, Department of Oncology
    Sep 1, 2020

    Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial

    Withdrawn
    • Anatomic Stage 0 Breast Cancer AJCC v8
    • +28 more
    • Carbon Dioxide Fractional Laser
    • Questionnaire Administration
    • (no location specified)
    Jan 5, 2023

    Low Grade Endometrial Stromal Sarcoma Trial in France (Aromatase Inhibitors)

    Recruiting
    • Low Grade Endometrial Stromal Sarcoma
    • Aromatase Inhibitors
    • Besançon, France
    • +19 more
    Aug 2, 2021

    UTERINE LEIOMYOMA Trial (VAGINAL HYSTERECTOMY)

    Terminated
    • UTERINE LEIOMYOMA
    • VAGINAL HYSTERECTOMY
    • (no location specified)
    Aug 12, 2020

    Breast Cancer Trial in Worldwide (Ribociclib, Letrozole or Anastrozole, Goserelin)

    Active, not recruiting
    • Breast Cancer
    • Mobile, Alabama
    • +90 more
    Dec 19, 2022

    Breast Cancer, Medication Adherence Trial in Singapore (SMS reminder)

    Completed
    • Breast Cancer
    • Medication Adherence
    • SMS reminder
    • Singapore, Singapore
    • +1 more
    Jun 25, 2020

    Breast Cancer Trial in Chandigarh (Tamoxifen, Letrozole)

    Unknown status
    • Breast Cancer
    • Chandigarh, India
      Department of Radiotherapy, Post Graduate Institute of Medical E
    Mar 2, 2020

    Hypogonadism, Severe Obesity Trial in Houston (Anastrazole, weight loss)

    Completed
    Has Results
    • Hypogonadism
    • Severe Obesity
    • Houston, Texas
      Michael E. DeBakey Veterans Affairs Medical Center
    Jan 20, 2020

    Hemostatic Profiles of Endocrine Therapies for Breast Cancer

    Completed
    • Breast Neoplasms
    • Venous Thromboembolism
      • Geneva, Switzerland
        Geneva University Hospitals
      Apr 7, 2020